146 related articles for article (PubMed ID: 11997271)
1. First clinical experience with a paclitaxel derivate-eluting polymer stent system implantation for in-stent restenosis: immediate and long-term clinical and angiographic outcome.
Liistro F; Stankovic G; Di Mario C; Takagi T; Chieffo A; Moshiri S; Montorfano M; Carlino M; Briguori C; Pagnotta P; Albiero R; Corvaja N; Colombo A
Circulation; 2002 Apr; 105(16):1883-6. PubMed ID: 11997271
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of late in-stent restenosis after implantation of a paclitaxel derivate-eluting polymer stent system in humans.
Virmani R; Liistro F; Stankovic G; Di Mario C; Montorfano M; Farb A; Kolodgie FD; Colombo A
Circulation; 2002 Nov; 106(21):2649-51. PubMed ID: 12438288
[TBL] [Abstract][Full Text] [Related]
3. Treatment of in-stent restenosis with sirolimus-eluting-stents -- a six month clinical and angiographic follow-up.
Rau M; Maikowski C; Weber M; Keil E; Elsässer A; Möllmann H; Hamm C
Z Kardiol; 2005 Nov; 94(11):742-7. PubMed ID: 16258776
[TBL] [Abstract][Full Text] [Related]
4. 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: an intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE).
Kataoka T; Grube E; Honda Y; Morino Y; Hur SH; Bonneau HN; Colombo A; Di Mario C; Guagliumi G; Hauptmann KE; Pitney MR; Lansky AJ; Stertzer SH; Yock PG; Fitzgerald PJ
Circulation; 2002 Oct; 106(14):1788-93. PubMed ID: 12356631
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the slow-release polymer-based paclitaxel-eluting Taxus-Express stent with the bare-metal Express stent for saphenous vein graft interventions.
Wöhrle J; Nusser T; Kestler HA; Kochs M; Hombach V
Clin Res Cardiol; 2007 Feb; 96(2):70-6. PubMed ID: 17146605
[TBL] [Abstract][Full Text] [Related]
6. Paclitaxel-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the TAXUS V ISR randomized trial.
Stone GW; Ellis SG; O'Shaughnessy CD; Martin SL; Satler L; McGarry T; Turco MA; Kereiakes DJ; Kelley L; Popma JJ; Russell ME;
JAMA; 2006 Mar; 295(11):1253-63. PubMed ID: 16531618
[TBL] [Abstract][Full Text] [Related]
7. TAXUS III Trial: in-stent restenosis treated with stent-based delivery of paclitaxel incorporated in a slow-release polymer formulation.
Tanabe K; Serruys PW; Grube E; Smits PC; Selbach G; van der Giessen WJ; Staberock M; de Feyter P; Müller R; Regar E; Degertekin M; Ligthart JM; Disco C; Backx B; Russell ME
Circulation; 2003 Feb; 107(4):559-64. PubMed ID: 12566366
[TBL] [Abstract][Full Text] [Related]
8. High-dose 7-hexanoyltaxol-eluting stent with polymer sleeves for coronary revascularization: one-year results from the SCORE randomized trial.
Grube E; Lansky A; Hauptmann KE; Di Mario C; Di Sciascio G; Colombo A; Silber S; Stumpf J; Reifart N; Fajadet J; Marzocchi A; Schofer J; Dumas P; Hoffmann R; Guagliumi G; Pitney M; Russell ME;
J Am Coll Cardiol; 2004 Oct; 44(7):1368-72. PubMed ID: 15464315
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of Paclitaxel-eluting stent restenosis with sirolimus-eluting stent implantation: angiographic and clinical outcomes].
Byrne R; Iijima R; Mehilli J; Pache J; Schulz S; Schömig A; Kastrati A
Rev Esp Cardiol; 2008 Nov; 61(11):1134-9. PubMed ID: 19000488
[TBL] [Abstract][Full Text] [Related]
10. Randomized double-blind comparison of sirolimus-eluting stent versus bare-metal stent implantation in diseased saphenous vein grafts: six-month angiographic, intravascular ultrasound, and clinical follow-up of the RRISC Trial.
Vermeersch P; Agostoni P; Verheye S; Van den Heuvel P; Convens C; Bruining N; Van den Branden F; Van Langenhove G
J Am Coll Cardiol; 2006 Dec; 48(12):2423-31. PubMed ID: 17174178
[TBL] [Abstract][Full Text] [Related]
11. Randomized trial of paclitaxel- versus sirolimus-eluting stents for treatment of coronary restenosis in sirolimus-eluting stents: the ISAR-DESIRE 2 (Intracoronary Stenting and Angiographic Results: Drug Eluting Stents for In-Stent Restenosis 2) study.
Mehilli J; Byrne RA; Tiroch K; Pinieck S; Schulz S; Kufner S; Massberg S; Laugwitz KL; Schömig A; Kastrati A;
J Am Coll Cardiol; 2010 Jun; 55(24):2710-6. PubMed ID: 20226618
[TBL] [Abstract][Full Text] [Related]
12. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.
Stone GW; Ellis SG; Cox DA; Hermiller J; O'Shaughnessy C; Mann JT; Turco M; Caputo R; Bergin P; Greenberg J; Popma JJ; Russell ME;
N Engl J Med; 2004 Jan; 350(3):221-31. PubMed ID: 14724301
[TBL] [Abstract][Full Text] [Related]
13. First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes.
Belkacemi A; Agostoni P; Nathoe HM; Voskuil M; Shao C; Van Belle E; Wildbergh T; Politi L; Doevendans PA; Sangiorgi GM; Stella PR
J Am Coll Cardiol; 2012 Jun; 59(25):2327-37. PubMed ID: 22503057
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, multicenter comparison study of triple antiplatelet therapy with dual antiplatelet therapy to reduce restenosis after drug-eluting stent implantation in long coronary lesions: results from the DECLARE-LONG II (Drug-Eluting Stenting Followed by Cilostazol Treatment Reduces Late Restenosis in Patients with Long Coronary Lesions) trial.
Lee SW; Park SW; Kim YH; Yun SC; Park DW; Lee CW; Kang SJ; Park SJ; Lee JH; Choi SW; Seong IW; Lee NH; Cho YH; Shin WY; Lee SJ; Lee SW; Hyon MS; Bang DW; Choi YJ; Kim HS; Lee BK; Lee K; Park HK; Park CB; Lee SG; Kim MK; Park KH; Park WJ;
J Am Coll Cardiol; 2011 Mar; 57(11):1264-70. PubMed ID: 21392640
[TBL] [Abstract][Full Text] [Related]
15. Patency of paclitaxel-eluting versus bare metal stents long term after implantation in acute ST-segment elevation myocardial infarction.
Vink MA; Van Nooijen FC; Laarman GJ; Suttorp MJ; Tijssen JG; Slagboom T; Patterson MS; Van Der Schaaf RJ; Kiemeneij F; Amoroso G; Dirksen MT
Am J Cardiol; 2011 Nov; 108(9):1214-9. PubMed ID: 21864813
[TBL] [Abstract][Full Text] [Related]
16. Impact of obesity on revascularization and restenosis rates after bare-metal and drug-eluting stent implantation (from the TAXUS-IV trial).
Nikolsky E; Kosinski E; Mishkel GJ; Kimmelstiel C; McGarry TF; Mehran R; Leon MB; Russell ME; Ellis SG; Stone GW
Am J Cardiol; 2005 Mar; 95(6):709-15. PubMed ID: 15757595
[TBL] [Abstract][Full Text] [Related]
17. Six- and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer.
Grube E; Sonoda S; Ikeno F; Honda Y; Kar S; Chan C; Gerckens U; Lansky AJ; Fitzgerald PJ
Circulation; 2004 May; 109(18):2168-71. PubMed ID: 15123533
[TBL] [Abstract][Full Text] [Related]
18. Use of Taxus polymer-coated paclitaxel-eluting stents for treatment of in-stent restenosis in real world patients: results of clinical and angiographic follow-up at six months in a single-center registry.
Lim VY; Buellesfeld L; Gerckens U; Mueller R; Schmidt T; Grube E
Catheter Cardiovasc Interv; 2006 Sep; 68(3):343-8. PubMed ID: 16897778
[TBL] [Abstract][Full Text] [Related]
19. A comparison of clinical and angiographic outcomes after Excel bioabsorbable polymer versus Firebird durable polymer rapamycin-eluting stent for the treatment of coronary artery disease in a "real world" setting: six-month follow-up results.
Liu HB; Xu B; Qiao SB; Yang YJ; Ma WH; Qin XW; Yao M; Wu YJ; Yuan JQ; Chen J; You SJ; Dai J; Xia R; Li JJ; Chen JL; Gao RL
Chin Med J (Engl); 2007 Apr; 120(7):574-7. PubMed ID: 17442205
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
